Tag Archives: Zavante Therapeutics

CDC Report on Pan-Resistant NDM Klebsiella in Nevada– A Sad Tale

Posted on by — No Comments ↓

During the past few weeks the case of a patient with MDR Klebsiella infection has made the news. We are told that this particular pathogen is “resistant to 26 antibiotics”. We were informed that the patient had multiple prior hospitalizations Continue reading CDC Report on Pan-Resistant NDM Klebsiella in Nevada– A Sad Tale→

A Renaissance for Old Drugs: Fosfomycin and Colistin

Posted on by — No Comments ↓

Fosfomycin Who would have thought that a drug that has been around since 1969 [2] could become eligible for QIDP status in 2015? Well, Zavante Therapeutics recently garnered the coveted QIDP designation for fosfomycin IV. This formulation has been available Continue reading A Renaissance for Old Drugs: Fosfomycin and Colistin→